1. Home
  2. BIVI vs RGS Comparison

BIVI vs RGS Comparison

Compare BIVI & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIVI
  • RGS
  • Stock Information
  • Founded
  • BIVI 2013
  • RGS 1922
  • Country
  • BIVI United States
  • RGS United States
  • Employees
  • BIVI N/A
  • RGS N/A
  • Industry
  • BIVI Biotechnology: Pharmaceutical Preparations
  • RGS Other Consumer Services
  • Sector
  • BIVI Health Care
  • RGS Consumer Discretionary
  • Exchange
  • BIVI Nasdaq
  • RGS Nasdaq
  • Market Cap
  • BIVI 20.1M
  • RGS 47.0M
  • IPO Year
  • BIVI N/A
  • RGS 1991
  • Fundamental
  • Price
  • BIVI $1.02
  • RGS $17.53
  • Analyst Decision
  • BIVI Strong Buy
  • RGS
  • Analyst Count
  • BIVI 1
  • RGS 0
  • Target Price
  • BIVI $30.00
  • RGS N/A
  • AVG Volume (30 Days)
  • BIVI 297.1K
  • RGS 24.6K
  • Earning Date
  • BIVI 05-13-2025
  • RGS 04-30-2025
  • Dividend Yield
  • BIVI N/A
  • RGS N/A
  • EPS Growth
  • BIVI N/A
  • RGS N/A
  • EPS
  • BIVI N/A
  • RGS 40.46
  • Revenue
  • BIVI N/A
  • RGS $191,336,000.00
  • Revenue This Year
  • BIVI N/A
  • RGS N/A
  • Revenue Next Year
  • BIVI N/A
  • RGS N/A
  • P/E Ratio
  • BIVI N/A
  • RGS $0.52
  • Revenue Growth
  • BIVI N/A
  • RGS N/A
  • 52 Week Low
  • BIVI $0.99
  • RGS $3.87
  • 52 Week High
  • BIVI $7.50
  • RGS $35.50
  • Technical
  • Relative Strength Index (RSI)
  • BIVI 23.10
  • RGS 33.23
  • Support Level
  • BIVI $1.09
  • RGS $18.00
  • Resistance Level
  • BIVI $1.24
  • RGS $19.91
  • Average True Range (ATR)
  • BIVI 0.10
  • RGS 1.37
  • MACD
  • BIVI -0.01
  • RGS -0.28
  • Stochastic Oscillator
  • BIVI 6.67
  • RGS 0.60

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

About RGS Regis Corporation

Regis Corp owns, franchises, and operates beauty salons throughout North America and the United Kingdom. The company's locations provide salon products and services to the mass market, including haircutting, styling, and hair coloring. The vast majority of Regis' salons are in strip malls, shopping centers, and Wal-Mart stores in North America and serve price-conscious customers. The company derives the majority of its revenue from these locations. The sale of products also contributes a relatively significant percentage of total sales. Regis also operates a smaller portfolio of premium salons across North America and the U.K. The company's majority brands include SmartStyle, Cost Cutters, and Supercuts.

Share on Social Networks: